Introduction
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, EC 1.2.1.12), a key enzyme in the glycolytic pathway, is considered a multifunctional protein involved in numerous cellular processes in mammalian cells (reviewed in Sirover, 2005 Sirover, , 2011 . In bacteria, nonglycolytic GAPDH functions have been associated with its extracellular location. GAPDH is one of the housekeeping proteins secreted by pathogens that interact with different host components, being involved in adhesion and/or virulence (Alvarez-Dominguez et al., 2008; Jin et al., 2005; Lama et al., 2009; Pancholi and Chhatwal, 2003; Schaumburg et al., 2004; Seifert et al., 2003; Terao et al., 2006) .
In gram-negative pathogens, GAPDH was shown to be secreted into the medium in a soluble and active form by enterohemorragic Escherichia coli (EHEC) and enteropathogenic E. coli (EPEC). In these pathogens, secretion is not linked to outer membrane vesicles and depends on growth conditions. The protein is secreted at 37°C by cells grown in LB or in eukaryotic culture media such as DMEM or Ham's F-12, but not in glucose-minimal medium (Egea et al., 2007) . E. coli GAPDH binds human plasminogen and fibrinogen and remains associated with Caco-2 cells upon infection (Egea et al., 2007) .
In addition, we have shown that the secreted protein can act as a target of oxidation and may therefore protect bacteria against host oxidative response (Aguilera et al., 2009) .
Although descriptions of GAPDH on the surface of gram-positive bacteria or yeast can be traced back more than 15 years, the mechanism that directs its secretion is still unknown. In gram-negative bacteria eight major protein secretion systems have been described so far and named from T1SS to T8SS (Desvaux et al., 2009 ). The type III secretion system (T3SS) is a key determinant of virulence in many gram-negative bacteria, including animal and plant pathogens. T3SS is a complex protein export apparatus 5 composed of a multi-ring base, an inner rod and a protruding needle, which facilitates direct delivery of bacterial virulence proteins (effectors) into host cells (Izoré et al., 2011; Marlovits et al., 2006) . T3SS effectors play important roles in infection by modulating or disrupting cellular structures and functions or host immune responses (reviewed by Dean and Kenny, 2009 ).
EPEC and EHEC are members of a closely related family that intimately attach to intestinal epithelial cells and induce characteristic attaching and effacing (A/E) lesions on the host cell, causing diarrhea (Dean et al., 2005; Kaper et al., 2004) . The A/E phenotype consists of the loss of microvilli and the accumulation of actin filaments and other cytoskeletal proteins beneath adherent bacteria. In EPEC, the ability to induce the A/E effects is encoded in a 41-gene pathogenicity island, called the locus of enterocyte effacement (LEE) (MacDaniel and Kaper, 1997) . The components of the type III secretion system are encoded in this locus together with associated transcriptional regulators, chaperones and effector proteins.
A large number of proteins are secreted by T3SS into culture media (Deng et al., 2010) . These protein substrates can be divided in several categories based on their secretion hierarchy. Early substrates are components of the needle and inner rod. The needle complex secretes the LEE-encoded translocators EspA, EspB and EspD (intermediate substrates)
before the effectors (late substrates). Translocators are needed for translocation of the effectors into host cells (Luo and Donnenberg, 2006) . To date multiple type III effectors have been identified in EPEC, some of them are encoded within the LEE whereas others are encoded in distinct pathogenicity islands through the chromosome (reviewed by Dean and Kenny, 2009 ). The secretion hierarchy of translocators and effectors is regulated by SepL and SepD (Deng et al., 2005; O'Connell et al., 2004) .
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Type III effectors from many pathogens usually have an associated chaperone that is not secreted (class I chaperones) (Izoré et al., 2011; Parsot et al., 2003) . These chaperones are generally small soluble proteins (15-20 kDa) with an acidic pI that form homodimers that bind to the amino-terminal region of effectors and remain in the bacterial cell after translocation of the effectors into the host cell. However, in many cases, chaperones are not absolutely required for effector secretion (Parsot et al., 2003) . Chaperone-effector interactions occur mainly between secondary structured elements of the effector and hydrophobic patches present on the chaperone dimer (Parsot et al., 2003) . Multiples roles have been attributed to these chaperones such as substrate stabilization, prevention of substrate premature interactions with other partners in the bacterial cytoplasm or regulation of virulence gene expression (Page and Parsot, 2002) .
In EPEC, the LEE-encoded chaperone CesT was shown to interact with several type III effectors encoded within and outside the LEE pathogenicity island (Thomas et al., 2005; Thomas et al., 2007) . Through its interaction with the type III ATPase EscN, CesT promotes the recruitment of the cognate effectors to the T3SS apparatus for efficient secretion (Thomas et al., 2005 ).
Here we report that T3SS mediates GAPDH secretion in EPEC cells grown in DMEM and provide experimental evidence on a novel interaction between GAPDH and the general T3SS chaperone CesT. This interaction may stabilise a small population of GAPDH molecules in a secretion competent-state and target them to the type III secretion apparatus. This is the first description on CesT interaction with a housekeeping protein and its export through T3SS.
Materials and Methods

Bacterial strains and growth conditions.
E.coli strains and plasmids used in this study are listed in Table 1 . Bacterial cells were routinely grown at 37ºC in Luria-Bertani broth (LB). Where indicated cells were grown without shaking at 37ºC in LB or Dulbecco's modified Eagle's medium (DMEM) in a CO 2 incubator. Growth was monitored by measuring the optical density at 600 nm (OD 600 ).
When indicated, 5 mM IPTG was added to the medium as inducer of chromosome encoded-lacZ expression. When required, ampicillin (100 g/ml) or kanamycin (50 g/ml) was added to the medium.
Protein secretion assays.
Isolation of secreted proteins was performed as previously described (Egea et al., 2007) . Briefly, overnight cultures in LB were diluted 1:50 in the indicated culture media and incubated without shaking at 37ºC in a 5% CO 2 atmosphere. After 6-8 h of growth (OD 600 of 0.8) bacteria were collected by centrifugation (5,000 x g, 10 min, 4º C), and the supernatant was passed through a 0.22 m-pore-size filter (Millipore). The proteins in the filtrate were precipitated by incubation on ice for at least 1 h with 10% trichloroacetic acid (TCA). When indicated, 0.1% bovine serum albumin (BSA) was added to the filtered supernatant before TCA precipitation. The protein pellet was washed in 90% (v/v) ice-cold acetone, air-dried and suspended in loading buffer before being resolved by SDS-PAGE (Laemmli, 1970) . Collected bacteria were resuspended in loading buffer and kept for SDS-PAGE analysis. 8
DNA manipulation.
Bacterial genomic DNA was obtained using the Wizard Genomic DNA purification kit (Promega), and plasmid DNA was prepared using the Wizard Plus SV Midipreps DNA purification system (Promega). DNA manipulations in vitro were performed according to standard protocols (Sambrook and Rusell, 2001) . DNA fragments were amplified by PCR using chromosomal DNA as template. When necessary, specific restriction sites were incorporated at the 5'-end of the primers to facilitate the cloning of the fragments in the appropriate vector. PCR reactions were performed with Pfu DNA polymerase in standard conditions. DNA was sequenced using an automated ABI 377 DNA sequencer and fluorescent dye termination methods.
To obtain a plasmid construct expressing His 6 -CesT, the cesT gene was amplified by PCR using EPEC E2348/69 genomic DNA and primers CesT-pQE30-bam.fw (5'-CGC-GGATCCATGTCATCAAGATCTGAAC-3') and CesT-pQE30-hind.rv (5'-CGC-AAGCTTTTATCTTCCGGCGTAATAATG-3') and cloned into BamHI/HindIII digested plasmid pQE30 (Qiagen), yielding pQE-CesT. Restriction sites incorporated at the 5'end of the primers are underlined. The forward primer was designed to fuse the His 6 -tag in frame with cesT. Plasmid DNA was sequenced to ensure that no mutations have been introduced during the amplification reaction.
Pull-down experiments with His 6 -CesT.
Overproduction of His 6 -tagged CesT was achieved in transformed cells of strain M15
[pREP4] bearing the recombinant plasmid pQE-CesT after isopropyl--thiogalactoside (IPTG) induction (0.3 mM) in LB-ampicillin-kanamycin medium for 16 h at 37 °C. The protein was purifed under native conditions with Ni 2+ -nitrilotriacetic acid (NTA) resin (Qiagen). Centrifugations were performed at 4 °C, and column chromatography was carried out at room temperature. The cell pellet from a 15 ml culture of strain M15 [pREP4] bearing plasmid pQE-CesT was suspended in 1 ml of 50 mM sodium phosphate buffer, pH 8.0, containing 10 mM imidazole and 300 mM NaCl (binding buffer), and sonicated on ice.
The cell lysate was centrifuged at 15000 g, and the supernatant was incubated with 0.1 ml of Ni 2+ -NTA resin for 1 h at 4ºC with gentle shaking. After loading the mixture into a column, the resin was washed with 50 mM sodium phosphate buffer, pH 8.0, containing 20 mM imidazole and 300 mM NaCl (wash buffer).
Column-bound His 6 -CesT was equilibrated with binding buffer, followed by the addition of 0.5 ml of an EPEC cell extract (10 mg/ml) in binding buffer obtained from cells grown in DMEM by sonic disruption as described above. The flow-through fraction was kept for analysis. The column was washed 4 x 5 ml of wash buffer. A last 0.1ml wash was performed and kept for gel analysis. Recombinant His 6 -CesT and interacting proteins were then eluted with 0.1 ml of elution buffer (50 mM sodium phosphate buffer, pH 8.0, containing 300 mM imidazole and 300 mM NaCl) followed by SDS-PAGE and immunoblotting analysis.
Immunoblotting analysis.
For Western blot analysis, protein samples were separated on 10% SDS-PAGE and transferred to a HyBond-P polyvinylidene difluoride (PVDF) membrane by using a BioRad MiniTransblot apparatus. Equal numbers of bacteria were used to prepare samples (whole cell lysates or secreted proteins) for analysis. The membrane was blocked in PBS-0.05% Tween-20 and 5% skimmed milk (blocking solution) for 1 h at room temperature, and then incubated with specific antibodies against GAPDH (1:5,000 dilution in blocking solution) (Egea et al., 2007) Binding of GAPDH to CesT was analyzed by Far-Western assays (overlay immunoblotting). For these experiments recombinant GAPDH was expressed and purified using the Glutathione-S-transferase (GST) gene fusion system with recognition sites for factor Xa cleavage as described in detail previously (Egea et al., 2007) . Purified GAPDH was further purified by affinity chromatography with anti-factor Xa-agarose resin (Sigma)
to remove factor Xa.
For mono-dimensional Far-Western experiments, purified GAPDH (2.5 g) was separated on 10% SDS-PAGE and transferred to a PVDF membrane. After being blocked overnight with 1% gelatin in TBS buffer (20 mM Tris-HCl, 150 mM NaCl , pH 7.6), the membrane was incubated with purified His 6 -CesT (1 or 5 g/ml) diluted in TBS-0.05%
Tween-20 for 3 hours and then washed four times in the same buffer. To visualize interaction of GAPDH with CesT, the membrane was incubated with anti-His specific antibodies (1:5,000 dilution TBS-1% gelatin-0.05% Tween-20) for 16 h at 4ºC, and processed as described above using the ECL Western blotting kit to visualize the reactive 11 spots. The incubation step with purified His 6 -CesT was omitted as negative control. When indicated, purified GAPDH (5 g) was subjected to two-dimensional gel electrophoresis before being blotted onto the PVDF membrane, which was then incubated with purified His 6 -CesT (1 g/ml) and processed as described above.
Two-dimensional gel electrophoresis.
2D gel electrophoresis was performed using the Protean IEF-Cell (Bio-Rad). Purified recombinant GAPDH (5 g) was diluted in 125 l of rehydration buffer (9 M urea, 4%
CHAPS, 50 mM dithiothreitol, 0.5% immobilized pH gradient buffer and traces of bromophenol blue). Isoelectric focusing was performed in immobilized pH 5-8 gradient strips (BioRad). Second dimension SDS-PAGE was performed on 12.5% acrylamide gels that were processed for immunoblotting analysis. Parallel gels were silver-stained to visualize total protein.
Biolayer interferometry.
Octet Red (Fortebio) instrument with amine reactive biosensors was used to study kinetics of GAPDH -CesT interaction. Carboxylic groups on the sensor surface were Kinetic constants were obtained by fitting data to a 1:1 model after parallel reference sensor subtraction.
Results and discussion
GAPDH secretion through the LEE-encoded T3SS in EPEC.
Secretion of GAPDH by EPEC in culture media known to induce the expression of LEE-encoded genes (Egea et al., 2007) prompted us to examine whether the LEE-encoded T3SS is involved in GAPDH secretion in this pathogen. To this end, GAPDH secretion was analyzed in escN or espB mutant strains. It is well known that mutations in escN, the gene encoding the T3SS ATPase, abolish secretion of both translocator and effector proteins through this system. In contrast, mutations in espB, the gene encoding a hydrophobic translocon protein that is thought to form with EspD a translocation pore through the host membrane, disrupt translocation of effector proteins into host cells during infection but do not impair secretion of these proteins into the extracellular medium (Deng et al., 2004 , Luo and Donnenberg, 2006 , Luo and Donenberg, 2011 .
Cells of wild-type EPEC E2348/69 and the derived mutant strains CVD452
(escN::aphA3) and UMD864 (espB) were grown statically at 37ºC in DMEM or LB (a medium that promotes down-regulation of LEE-encoded T3SS) to an OD 600 of 0.8. When 13 indicated, cultures were incubated overnight. Proteins in the cell-free culture supernatants were collected by TCA precipitation and the presence of secreted GAPDH in these fractions was analyzed by Western blot. To rule out cytosolic contamination due to cell lysis, immunoblots were revealed with antibodies against the intracellular protein -galactosidase (Fig. 1) . Expression of -galactosidase was achieved by addition of 5 mM IPTG to the culture medium. Gels run in parallel were stained with Sypro® Ruby to visualize total secreted protein.
In cells grown in LB, no significant changes in the secretion profiles of the three strains were observed (Fig. 1A) . In these growth conditions GAPDH was secreted by all strains at the same extent. The absence of -galactosidase in culture supernatants ruled out cell lysis phenomena, and indeed proves GAPDH secretion by LB-grown EPEC through a non-dependent T3SS mechanism.
Regarding DMEM-cultured cells, as expected from the mutant phenotypes, the secretion profiles of wild-type EPEC and espB mutant were very similar, except for the 34 kDa-protein band (EspB) that is absent from the UMD864 cell-free supernatant. The secretion profile was clearly different for the escN mutant. In this case, almost no secreted proteins were apparent in cell-free supernatants (Fig. 1A) . The espB mutant UMD864 displayed reduced GAPDH secretion in DMEM compared with the wild-type strain. In this mutant, GAPDH was immunodetected in supernatants of overnight DMEM cultures (Fig.   1A ). In contrast, secretion of GAPDH was completely abolished in the escN insertion mutant CVD452 grown in DMEM at any incubation time (Fig. 1A) . The lack of GAPDH secretion in EPEC cells defective in the T3SS ATPase was confirmed with a non-polar escN mutant (Gauthier and Finlay, 2003) (Fig. 1B) . To normalize protein precipitation efficiency, TCA precipitation of cell free-supernatants was also performed in the presence of 0.1% BSA as a carrier. Immunoblotting analysis also failed to detect secreted GAPDH in both escN mutants in these conditions (not shown). GAPDH secretion was restored in the escN mutants by plasmid pCVD446 bearing the wild-type escN gene (Fig. 1B) . Overall, these results indicate that GAPDH may be secreted by the LEE-encoded T3SS in EPEC grown in DMEM.
In EPEC cells defective in SepD function, the secretion of type III translocon components is reduced while the T3SS-dependent secretion of several effectors is highly increased, hence aiding the identification of previously unrecognized type III secreted proteins (Deng et al., 2004 , 2005 , O'Connell et al., 2004 . Therefore, we set out to evaluate GAPDH secretion in DMEM cultures of a sepD mutant strain (Deng et al., 2005) . Equal numbers of bacteria were used to obtain the secreted proteins for Western blot analysis. As shown in Fig.1C , GAPDH secretion was enhanced in the sepD mutant when compared with the wild-type strain.
Results obtained with the espB, escN and sepD mutants show that GAPDH secretion profile follows that of the bona fide T3SS effectors thereby pointing to GAPDH as a putative type III effector protein in EPEC.
Interaction of GAPDH with the general type III chaperone CesT.
Although CesT was first described as a specific chaperone for the type III effectors Tir and Map, Thomas et al. (2005 Thomas et al. ( , 2007 showed, through an elegant work, that CesT is required for efficient secretion of many other type III effectors, some of them not encoded in the LEE pathogenicity island. We therefore set out to evaluate whether CesT can bind GAPDH. To this end, His-tagged CesT was purified and bound to a Ni 2+ -NTA column followed by the addition of wild-type EPEC cell extract (0.5 ml; 10 mg/ml) in binding buffer obtained from cultures grown in DMEM. In this experiment, proteins that interact with CesT are retained on the column and then can be co-eluted with CesT. After extensive washing, His 6 -CesT was eluted with elution buffer. The purification fractions were then subjected to SDS-PAGE followed by Western blot analysis with antibodies against GAPDH. Parallel samples were revealed by Coomassie blue staining. As shown in Fig. 2 the final wash fraction did not contain any detectable protein.
In the eluted fraction, in addition to the dominant protein His 6 -CesT, other proteins were visible. These proteins may correspond to EPEC effectors interacting with CesT (Thomas et al., 2005) . Immunoblotting of the column fractions with anti-GAPDH antibodies indicated that a fraction of this protein was bound and co-eluted with His 6 -CesT (Fig. 2, left panel) . In a control experiment, the EPEC cell extract was directly applied to the Ni 2+ -NTA column and processed in parallel.
Immunoblotting of the eluted fraction showed that the Ni 2+ -NTA resin did not bind GAPDH to any extent (Fig. 2, right panel) .
Since some type III efectors such as Tir directly bind EscN (Gauthier and Finley, 2003) , and this ATPase binds CesT, we set out to examine whether the observed GAPDHCesT interaction was dependent on EscN. Thus, the CesT column binding experiment was also performed with escN cell extracts obtained from DMEM cultures (Fig. 2, middle panel). Immunoblotting of the eluted fractions with anti-GAPDH antibodies revealed that GAPDH was bound on the column and co-eluted with His 6 -CesT, thus indicating that EscN is not necessary for CesT and GAPDH interaction. Retention of GAPDH on the CesTaffinity column was also observed with cell extracts of the laboratory strain E.coli M15[pREP4] . This result indicates that GAPDH interaction with CesT cannot be attributed to other bridging T3SS proteins and suggests direct GAPDH-CesT interaction.
Direct binding of GAPDH to CesT was confirmed by mono-dimensional Far-Western assays in which purified GAPDH was subjected to SDS-PAGE, transferred to PVDF membrane and reacted with soluble purified His 6 -CesT (Fig. 3A) . Since GAPDH is a target of multiple post-translational modifications we set out to analyze whether CesT binding activity is specifically linked to one of these forms. This was approached by Far-Western experiments, in which purified GAPDH was subjected to two-dimensional gel electrophoresis. Purified GAPDH yielded several spots that interacted with CesT ( Fig. 3B ), thus providing evidence that this binding is not strictly dependent on a GAPDH form.
The dissociation constants of GAPDH-CesT interaction were measured by biolayer interferometry (BLI), a technique that quantitates molecular interactions and provides the on/off rates. When we immobilized CesT and measured the affinity of the GAPDH-CesT complex (Fig. S1, supplemental (Stebbins and Galán, 2001) and (PDB ID: 1L2W) (Birtalan et al., 2002) (Fig. 4A) , the 120 N-terminal amino-acid residues of GAPDH could adopt a similarly extended conformation to bind the four canonical hydrophobic patches exposed across the chaperone dimer. Indeed, the secondary structure and the pattern of conserved hydrophobic and positively charged residues that are thought to mediate the interaction of T3SS effectors and their cognate chaperones are discernable, despite considerable degeneracy, along the GAPDH amino terminus (Fig. 4B) . Since the nascent, monomeric chain of GAPDH has been shown to interact with various chaperones and chaperonins as it emerges from the ribosome, like Trigger factor (Liu et al., 2010) and GroEL/GroES (Houry et al., 1999) , it becomes plausible for CesT to compete for a small fraction of nascent GAPDH amino termini thereby interfering with its intracellular stabilization and folding, and targeting GAPDH instead for T3SS-mediated secretion, with
proper folding and oligomerization taking place after translocation. The engagement of the GAPDH N-terminal segment in the interaction with CesT would imply the partial disruption of the GAPDH tetramer, since residues 41-51 contribute to the stabilization of the oligomerization interface (Fig. 4C ). This would be in keeping with the proposal that proteins targeted for secretion via T3SS should translocate in an unfolded, or partially folded, non-globular state through the 25-Å-wide inner diameter of the needle complex (Stebbins and Galán, 2003) . Taken together, these results indicate that a stable complex exists between the T3SS chaperone CesT and a particular GAPDH conformation, thereby providing a solid experimental underpinning for the redirection of a fraction of cytosolic GAPDH through the T3SS secretion system.
To analyze whether CesT function is essential for GAPDH secretion, immunoblotting experiments were performed with cell-free supernatants of DMEM cultures of a cesT mutant strain (Abe et al., 1999) . Equal numbers of bacteria (wild type EPEC and the cesT mutant) were used to obtain secreted proteins for analysis. As shown in Fig.1C , GAPDH secretion was not abolished but reduced in the cesT mutant. The fact that the cognate chaperone is not absolutely required for protein secretion seems to be rather common for type III effectors in several pathogens (Parsot et al., 2003) . Actually, there is evidence that Tir secretion is not strictly dependent on CesT as low levels of Tir can be detected in culture supernatants of cesT mutants (Elliot et al., 1999) .
This study describes for the first time the interaction of a housekeeping protein with the type III chaperone CesT. Interaction of GAPDH with this chaperone may provide the way by which GAPDH is targeted to the type III secretion apparatus and reinforce the idea that GAPDH is secreted by the LEE-encoded T3SS in EPEC cells grown in DMEM.
A T3SS-independent GAPDH secretion pathway is operative in EPEC and probiotic E. coli strains grown in LB.
Immunodetection of GAPDH in cell-free supernatants of the escN mutant strain CVD452 grown in LB (Fig. 1) indicated that a secretion system other than T3SS is responsible for GAPDH secretion in EPEC grown in this rich bacteriological medium. At this point we set out to study whether this alternative secretion system may also be active in non-pathogenic E. coli strains. In fact, in the last years several reports describe GAPDH secretion by some gram-positive probiotic strains of the genus Lactobacillus (Hurmalainen et al., 2007; Sanchez et al., 2008 Sanchez et al., , 2009a Sanchez et al., , 2009b (Ochman and Selander, 1984) and (ii) the probiotic E. coli strain Nissle 1917 (serotype O6:K5:H1). These bacterial cells were grown statically at 37ºC in DMEM or LB to an OD 600 of 0.8. Presence of secreted GAPDH in the culture supernatants was analyzed by
Western blot. None of the strains analyzed secreted GAPDH when grown in DMEM (Fig.   5 ). These strains do not contain in their chromosome the T3SS-encoding genes. Therefore, this result is in accordance with the involvement of the LEE-encoded T3SS in GAPDH secretion in EPEC grown in DMEM. In contrast, great differences in GAPDH secretion among strains were observed in LB cultures. Extracellular GAPDH was detected in the supernatant of the probiotic strain Nisssle 1917, but not in the supernatants of the natural isolates EcoR26 (Fig. 5 ), EcoR12 and EcoR41 (not shown). These results indicate that the secretion mechanism responsible for GAPDH export in LB is active in both pathogenic and probiotic E. coli strains. It may be hypothesized that GAPDH secretion may confer to these strains an advantage in the context of gut colonization with respect to other components of the intestinal microbiota. In fact, GAPDH secretion and its interaction with extracellular host components such as mucin or extracellular matrix proteins are rather common among diverse pathogens and probiotic microorganisms (Hurmalainen et al., 2007; Kinoshita et al., 2008; Lama et al., 2009; Pancholi and Chhatwal, 2003) .
Results presented in this study indeed prove that secretion of GAPDH in EPEC is mediated by at least two alternative pathways depending on the growth conditions: (i) the pathogen specific T3SS in cells grown in DMEM, and (ii) a system not yet identified in cells grown in LB, which is not restricted to pathogens but also operative in probiotic E.
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coli strains. The widespread presence of multiple GAPDH secretion pathways is compatible with GAPDH roles in colonization and infection processes. in an extended conformation (YopE), the region between the first conserved arginine/lysine and the last residue in the last -strand ranges from 31-35 residues. In contrast, the more condensed -helical structure of SptP (with a non-interacting, greyed-down -helical insertion and a third -helix) allows fitting 71 residues over the SicP chaperone. The effector sequence and secondary-structure motifs recognizable in GAPDH are labelled accordingly. (C) GAPDH monomer and dimer structure (PDB ID: 1DC5) (Yun et al., 2000) shown in cartoons and coloured in rainbow colours. Blue asterisks and plus signs have the same meaning as in (A) and (B) . N-terminal GAPDH residues predicted to interact with
Figure Legends
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CesT are shown in sticks and CPK colours. In particular, the amino acid stretch 41-51 forms part of a dimeric interface involving a patch of C-terminal residues (shown also in sticks) that is framed by dashed lines. The two symmetric interfaces bury a combined 980 Å 2 surface area stabilized by two symmetric sets of 6 hydrogen bonds and 1 salt bridge. 
